- Wednesday's session on equity markets promises to be positive. After yesterday's gains in Wall Street indices, the bullish trend was extended today by indices from Asian markets.
- The bullish trend on Wall Street was further supported yesterday by weak PMI data, which triggered a dovish reaction across all asset classes.
- The reaction to Tesla's results is also not insignificant. Shares of Elon Musk's company, rose 13% after the close of the session, despite the fact that its results came in below estimates.
- The key theme of the session in APAC markets was the inflation reading from Australia.
- The AUD/USD pair rose above 0.6500 after higher-than-forecast inflation data for Q1 2024. CPI for Q1 came in at +1.0% q/q (0.8% expected) and 3.6% y/y (3.4% expected).
- Such a macro reading, suggesting continued upward pressure on prices in the economy, may encourage the RBA to delay the interest rate cut cycle.
- In this numerous banking analysts suggest that the first such move may take place in September (even earlier July was suggested).
- The US Senate passed a bill to provide $95 billion in aid to Ukraine, Israel and Taiwan. The funds will be distributed as follows: $60.8 billion for Ukraine, $26.4 billion for Israel, and $8 billion for Taiwan.
- PBOC sets average USD/CNY fixing today at 7.1048 (vs. estimate of 7.2363)
- New Zealand reported a trade surplus in March. Exports showed a welcome increase, but imports fell to their lowest level since mid-2021.
- In the natural gas market, there was a contract rollover, which lifted commodity prices 14.5% higher.
- Gold and crude oil are gaining about 0.2% this morning. Cryptocurrencies are doing slightly better; where Bitcoin is adding 0.5%, Ethereum 1.4% and Algorand over 35%.
- The leader of the gains in the FX market today is the Australian dollar, which has broken out against the USD above the 0.6500 zone. source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
